Medtronic Signia SDR Product Surveillance Registry

NCT ID: NCT05095935

Last Updated: 2026-01-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

430 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-10

Study Completion Date

2024-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the registry is to confirm the safety and performance of the Signia™ Small Diameter Reload (SDR) when used in surgical procedures in a real-world setting in patients receiving surgery for indicated thoracic, abdominal, and pediatric applications, intraoperatively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Minimally Invasive Surgical Procedures Surgical Procedures, Operative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thoracic Adult

Use of Signia SDR for the transection of pulmonary arteries and veins in adult patients.

N/A observational registry

Intervention Type OTHER

N/A observational registry

Abdominal Adult

Use of Signia SDR for the transection of renal arteries and veins in adult patients.

N/A observational registry

Intervention Type OTHER

N/A observational registry

Abdominal Pediatric

Use of Signia SDR for the transection of the appendiceal stump and mesoappendix (simple acute appendicitis) in pediatric patients.

N/A observational registry

Intervention Type OTHER

N/A observational registry

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

N/A observational registry

N/A observational registry

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements
* Patient has, or is intended to receive or be treated with, an eligible Medtronic product
* Patient is consented within the enrollment window of the therapy received, as applicable

Exclusion Criteria

* Patient who is, or is expected to be, inaccessible for follow-up
* Patient is excluded by local law
* Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the PSR results
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cedars Sinai Medical Center

Los Angeles, California, United States

Site Status

Children's Hospital Colorado

Denver, Colorado, United States

Site Status

The George Washington University Hospital

Washington D.C., District of Columbia, United States

Site Status

Rush

Chicago, Illinois, United States

Site Status

Cooper Health System

Camden, New Jersey, United States

Site Status

NYU Langone Medical Center

New York, New York, United States

Site Status

New York Presbyterian Hospital - Colombia University Medical Center

New York, New York, United States

Site Status

UNC Chapel Hill

Chapel Hill, North Carolina, United States

Site Status

Duke University Health Systems

Durham, North Carolina, United States

Site Status

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

UPMC Falk Clinic

Pittsburgh, Pennsylvania, United States

Site Status

University of Texas - San Antonio

San Antonio, Texas, United States

Site Status

Virginia Cancer Specialists

Fairfax, Virginia, United States

Site Status

Mary Washington Hopital

Fredericksburg, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Surgical PSR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TYRX™ Pocket Health Study
NCT05356546 COMPLETED
Sinai Vein Stent Registry
NCT02600936 RECRUITING
SMART-IC-Pilot Study
NCT07336433 NOT_YET_RECRUITING NA
Zenith® Dissection Clinical Trial
NCT01568320 COMPLETED NA